Viewing Study NCT06355206



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06355206
Status: RECRUITING
Last Update Posted: 2024-05-09
First Post: 2024-03-28

Brief Title: Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis
Sponsor: Changhai Hospital
Organization: Changhai Hospital

Study Overview

Official Title: Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis a Prospective Cohort Study
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NACRE
Brief Summary: The goal of this observational cohort study is to learn about the etiology natural course therapeutic effect and outcome of recurrent acute pancreatitis patients The main question it aims to answer is

Does endoscopic intervention surgery or conservative treatment reduce the recurrence of acute pancreatitis What are the risk factors affecting the recurrence of acute pancreatitis

Patients will be closely followed and clinical information will be recorded
Detailed Description: Acute pancreatitis is one of the most common causes of acute hospital admission which is unpredictable and contributes to high health-care costs even death Recurrent acute pancreatitis is defined as two or more discrete episodes of acute pancreatitis and has an estimated annual incidence of 8-10 per 100 000 Cholelithiasis alcohol and Hyperglyceremia are the most commonly recognized causes of acute pancreatitis About 80 of RAP patients can be identified through routine investigations identify include proper history physical examination CT MRI endoscopic ultrasound however in up to 20 of cases whose cause remains unclear are known as idiopathic RAP For RAP patients with clear cause removal of the cause can effectively reduce or prevent recurrence For patients with idiopathic RAP the treatment options are not clear and have been subject to debate At present the natural course outcome and therapeutic effect of RAP is still not clear Therefore the prospective cohort can clarify the clinical characteristics of RAP more comprehensively and deeply and to accumulate evidence for treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None